{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T04:16:22Z","timestamp":1744258582346,"version":"3.40.4"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","award":["U24AT009676"],"award-info":[{"award-number":["U24AT009676"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s11606-021-07087-8","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T14:03:04Z","timestamp":1628776984000},"page":"1658-1664","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Patients\u2019 Reactions to Letters Communicating Collateral Findings of Pragmatic Clinical Trials: a National Web-Based Survey"],"prefix":"10.1007","volume":"37","author":[{"given":"Kevin P.","family":"Weinfurt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juli M.","family":"Bollinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"May","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail","family":"Geller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra J. H.","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie R.","family":"Morain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorrie","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane L.","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Sugarman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,12]]},"reference":[{"key":"7087_CR1","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1007\/s11606-020-06113-5","volume":"35","author":"J Bollinger","year":"2020","unstructured":"Bollinger J, Geller G, Weinfurt K, et al. Patients\u2019 views about the disclosure of collateral findings in pragmatic clinical trials: a focus group study. J Gen Intern Med 2020;35:3436-3442.","journal-title":"J Gen Intern Med"},{"key":"7087_CR2","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1177\/1740774515598334","volume":"12","author":"RM Califf","year":"2015","unstructured":"Califf RM, Sugarman J. Exploring the ethical and regulatory issues in pragmatic clinical trials. Clin Trials 2015;12:436-441.","journal-title":"Clin Trials"},{"key":"7087_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ijchp.2014.12.001","volume":"15","author":"SC Evans","year":"2015","unstructured":"Evans SC, Roberts MC, Keeley JW, et al. Vignette methodologies for studying clinicians\u2019 decision-making: validity, utility, and application in ICD-11 field studies. Int J Clin Health Psychol 2015;15:160-170.","journal-title":"Int J Clin Health Psychol"},{"key":"7087_CR4","unstructured":"Ipsos. KnowledgePanel\u00ae: A Methodologic Overview. Accessed Nov. 21, 2020. https:\/\/www.ipsos.com\/sites\/default\/files\/ipsosknowledgepanelmethodology.pdf"},{"key":"7087_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1080\/15265161.2020.1689031","volume":"20","author":"S Morain","year":"2020","unstructured":"Morain S., Weinfurt K, Bollinger J, Geller G, Mathews D, Sugarman J. Ethics and collateral findings in pragmatic clinical trials. Am J Bioeth 2020;20:6-18.","journal-title":"Am J Bioeth"},{"key":"7087_CR6","first-page":"e10245","volume":"2020","author":"S Morain","year":"2020","unstructured":"Morain S, Mathews D, Weinfurt K, et al. 2020. Stakeholder perspectives regarding pragmatic clinical trial collateral findings. Learn Health Syst 2020;e10245.","journal-title":"Learn Health Syst"},{"key":"7087_CR7","doi-asserted-by":"crossref","unstructured":"Ulrich CM, Ratcliffe SJ. Hypothetical vignettes in empirical bioethics research. In: Jacoby L, Siminoff LA, eds. Empirical Methods for Bioethics: A Primer. Volume 11. Advances in Bioethics. JAI Press; 2008:161-181.","DOI":"10.1016\/S1479-3709(07)11008-6"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-021-07087-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-021-07087-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-021-07087-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T09:26:46Z","timestamp":1744190806000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-021-07087-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,12]]},"references-count":7,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["7087"],"URL":"https:\/\/doi.org\/10.1007\/s11606-021-07087-8","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"type":"print","value":"0884-8734"},{"type":"electronic","value":"1525-1497"}],"subject":[],"published":{"date-parts":[[2021,8,12]]},"assertion":[{"value":"16 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Sugarman is a member of Merck KGaA\u2019s Bioethics Advisory Panel and Stem Cell Research Oversight Committee; a member of IQVIA\u2019s Ethics Advisory Panel; a member of Aspen Neurosciences\u2019 Scientific Advisory Board; a consultant for Biogen; and a consultant for Portola Pharmaceuticals, Inc. None of these activities is related to the material discussed in this manuscript. No other authors reported conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The views presented here are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}